1254P Radical radiotherapy (RT) and chemoradiotherapy (CRT) in non-small cell lung cancer (NSCLC): Outcomes from a regional cancer network

por Abdul-Latif, M.A., English, S., Fernandes, J., Singer, J., Chowdhury, S., Anand, G.
Publicado 2020

1709P Cancer patients' perspectives on the real-world impact of COVID-19 pandemic: A multidisciplinary survey

por Bao, K.K.H., Cheung, K.M., Chow, J.C.-H., Leung, C.W.L., Tsui, W., Lau, A., Tse, T., Wan, S., Kwok, M., Wong, K.H.
Publicado 2020

1680P SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy

por Hempel, D., Milani, V., Kleespies, A., Hempel, L., Ebner, F., Zehn, D., Keim, S.
Publicado 2020

1748P Real-world outcomes in thoracic cancer patients (pts) with severe acute respiratory syndrome coronavirus 2 (COVID-19): Single UK institution experience

por Cui, W., Yousaf, N., Bhosle, J., Minchom, A.R., Ahmed, M., McDonald, F., Locke, I., Lee, R., O'Brien, M., Popat, S.
Publicado 2020

1581O Estimation of European cancer burden for the year 2020

por Dyba, T.A., Randi, G., Martos, M.D.C., Giusti, F., Ferlay, J., Bray, F., Dimitrova, N., Neamtiu, L., Nicholson, N., Carvalho, R., Bettio, M.
Publicado 2020

1690P Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19

por Lee, R., Zhou, C., Shotton, R., Tivey, A., Dickens, E., Huddar, P., McKenzie, H., Boyce, H., Maynard, A., Rowe, M.P., Khan, S., Eastlake, L., Angelakas, A., Baxter, M., Copson, E., Horsley, L., Thomas, A., Wilson, C., Cooksley, T., Armstrong, A.
Publicado 2020

1888P Hepatitis screening in oncology patients planned to receive systemic anti-cancer therapy (SACT)

por Kieran, R., O'Donnell, D.M.
Publicado 2020

1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy

por Banna, G.L., Cantale, O., Friedlaender, A., Addeo, A.
Publicado 2020

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 rando...

por Giaccone, G., Felip, E., Cobo, M., Campelo, R. Garcia, DENIS, F., Quoix, E., Madroszyk, A., Debieuvre, D., Hilgers, W., Moran, T., Galetta, D., Romano, G.D., Cappuzzo, F., Robinet, G., Masson, P., Viteri, S., Peled, N., Costantini, D., Dziadziuszko, R., Besse, B.
Publicado 2020

1760P COVID-19 severe pneumonia in cancer patients: Impact and predictive factors

por Peinado, P., Sanz Garcia, E., Moreno, I., Dorta, M., Alvarez, B., Alvarez Gallego, R., Madurga, R., Ugidos, L., Rodriguez Pascual, J., Muñoz, C., Garcia-Rico, E., Cubillo, A.
Publicado 2020

1703P UK Coronavirus Cancer Monitoring Project (UKCCMP): A national reporting network for real time data of the COVID-19 pandemic

por Olsson-Brown, A.C., Hughes, D.J., Purshouse, K., Lee, L., Cheng, V.W., Lee, A.J.X., Protheroe, E., Smith, A., Curley, H., Arnold, R., Cazier, J-B., D'Costa, J., Palles, C., Campton, N., Varnai, C., Sivakumar, S., Kerr, R., Middleton, G.
Publicado 2020

1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak

por Pastorino, A., Negru, M.E., Vigani, A., Vaira, F., Tognoni, A., Ferrari, A., Ricci, I., Rondini, M., Olcese, F., Milano, A., Cozzani, F., Aschele, C.
Publicado 2020

1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic

por Benusiglio, P.R., Korenbaum, C., Ezenfis, J., Geoffron, S., Paul, C., Richard, S., Byrde, V., Guillerm, E., Basset, N., Lotz, J-P., Chabbert-Buffet, N., Gligorov, J., Coulet, F.
Publicado 2020

LBA70_PR The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration

por Banerjee, S., Lim, K.H.J., Kamposioras, K.V., Murali, K., Oing, C., Punie, K., O'Connor, M., Devnani, B., Lambertini, M., Benedikt Westphalen, C., Garrido Lopez, P., Amaral, T.M.S., Thorne, E., Morgan, G., Haanen, J.B.A.G., Hardy, C.
Publicado 2020

1716P Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2

por Jay, C., Stanbery, L., Kerneis, F., Nemunaitis, J., Aaron, P., Manning, L., Wallraven, G., Shanahan, D., Shen, Y., Senzer, N., Bognar, E.
Publicado 2020

1721P Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres

por Aguinaga, L., Ursu, R., Legoff, J., Delauguerre, C., Nguyen, O., Harel, S., Royer, B., sebert, M., Jachiet, M., Lebbé, C., Bonnet, C., Brice, P., Fenaux, P., Plaud, B., Aparicio, T.
Publicado 2020

1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre

por Wu, A., Sng, C.C.T., Benafif, S., Chopra, N., Galazi, M., Lee, A.J.X., Ottaviani, D., Soosaipillai, G.B., Wong, Y.N.S., Shaw, H.M.
Publicado 2020

1684P Scientia Potentia Est: How the Italian world of oncology changes in the COVID-19 pandemic

por Ballatore, Z., Bastianelli, L., Merloni, F., Ranallo, N., Cantini, L., Mariotti, L., Lucarelli, A., Burattini, M., Berardi, R.
Publicado 2020

CN3 New blended-learning module for breast care nurses in Switzerland

por Gresch, B.
Publicado 2020

1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia

por Cavic, M., Krivokuca, A., Damjanovic-Velickovic, A., Pavlovic, M., Mihajlovic, M., Rakobradovic, J., Boljevic, I., Malisic, E., Tanic, M., Jankovic, R.
Publicado 2020